Risk factors for recurrence in borderline tumours

Por um escritor misterioso

Descrição

Risk factors for recurrence in borderline tumours
Diagnosis, treatment, and follow-up of borderline ovarian tumors. - Abstract - Europe PMC
Risk factors for recurrence in borderline tumours
JCM, Free Full-Text
Risk factors for recurrence in borderline tumours
Full article: Risk factors for recurrence of borderline ovarian tumours: A tertiary centre experience
Risk factors for recurrence in borderline tumours
Borderline tumor - Wikipedia
Risk factors for recurrence in borderline tumours
Borderline Ovarian Tumors a Five-year Retrospective Clinicopathologic Study of 69 Cases in Egyptian NCI (2013-17)
Risk factors for recurrence in borderline tumours
PDF) Pathology of borderline (low malignant potential) ovarian tumours
Risk factors for recurrence in borderline tumours
KoreaMed Synapse
Risk factors for recurrence in borderline tumours
Diagnosis, treatment, and follow-up of borderline ovarian tumors. - Abstract - Europe PMC
Risk factors for recurrence in borderline tumours
Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence - The Lancet Oncology
Risk factors for recurrence in borderline tumours
Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea
Risk factors for recurrence in borderline tumours
The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision, World Journal of Surgical Oncology
Risk factors for recurrence in borderline tumours
Fertility sparing treatment in borderline ovarian tumours - ecancer
Risk factors for recurrence in borderline tumours
MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges
Risk factors for recurrence in borderline tumours
Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
Risk factors for recurrence in borderline tumours
Frontiers Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
de por adulto (o preço varia de acordo com o tamanho do grupo)